Please login to the form below

Olmesartan franchise

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Olmesartan franchise was produced by Daiichi Sankyo.

Alexion eyes Soliris combo with $930m deal to buy Achillion

Meanwhile, for Achillion the takeover by Alexion marks a renaissance for the company, which had to reinvent itself after a once-promising hepatitis C virus franchise faded away, taking partner Johnson

Gilead promotes Andrew Dickinson to CFO, increased M&A expected

The new CEO is focused on steering Gilead away from relying on its HIV franchise, as it looks to expand into immuno-oncology and other lucrative therapy areas.

FDA approves Lilly’s migraine drug Reyvow

Reyvow will join another recently approved migraine product, the CGRP antagonist Emgality, in Lilly’s franchise.

Gilead builds case for Xeljanz rival filgotinib as it preps US filing

its HIV franchise, to include new areas like cancer, liver disease and immunology.

Novo Nordisk, bluebird team up to develop haemophilia A therapies

s key diabetes franchise is also under pressure.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology